Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Catrina Ting
Institution:
Roswell Park Comprehensive Cancer Center
Observed institution:
Roswell Park Comprehensive Cancer Center
ORCID:
0009-0003-2761-8599
Observed ORCID:
0009-0003-2761-8599
OpenAlex ID:
A5089289059
Tumor-Derived Complement C3 Overexpression in STK11 -Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
·
Cancer Immunology Research
·
3
Abstract 108: Tumor-derived complement C3 is overexpressed in STK11 mutant non-small cell lung cancer and contributes to an immunosuppressive tumor microenvironment in a syngeneic mouse model
2024
·
Sora Suzuki
, Catrina Ting
, et al.
·
Cancer Research
·
1
Abstract 3404: Detection of circulating tumor DNA using CRISPR-Cas13a in non-small cell lung cancer
2022
·
Edwin H. Yau
, Bojidar Kandar
, et al.
·
Cancer Research
·
1
Figure S5 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Table S1 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S2 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S3 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S10 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Table S2 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S8 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S7 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Data from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S4 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S1 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S6 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Figure S9 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Table S3 from Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance
2026
·
Sora Suzuki
, Bojidar Kandar
, et al.
Abstract 2915: Targeting complement factor H renders STK11-mutant lung adenocarcinoma sensitive to anti-PD-1 therapy in mice
2024
·
Sora Suzuki
, Anm Nazmul Khan
, et al.
·
Cancer Research
66 Tumor-derived complement is required for tumor growth in syngeneic murine STK11-mutant lung adenocarcinoma
2023
·
Sora Suzuki
, ANM Nazmul Khan
, et al.
·
Immunobiology
Show more works
View as search
Works count:
19
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type